Jagsonpal Pharmaceuticals Statistics

Total Valuation

Jagsonpal Pharmaceuticals has a market cap or net worth of INR 17.40 billion. The enterprise value is 16.71 billion.

Market Cap	17.40B
Enterprise Value	16.71B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	Sep 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.38%
Shares Change (QoQ)	-2.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.72M

Valuation Ratios

The trailing PE ratio is 71.58.

PE Ratio	71.58
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	16.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.88, with an EV/FCF ratio of 29.19.

EV / Earnings	68.79
EV / Sales	7.37
EV / EBITDA	50.88
EV / EBIT	58.40
EV / FCF	29.19

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.05.

Current Ratio	2.95
Quick Ratio	2.07
Debt / Equity	0.05
Debt / EBITDA	0.30
Debt / FCF	0.17
Interest Coverage	33.67

Financial Efficiency

Return on equity (ROE) is 13.26% and return on invested capital (ROIC) is 9.28%.

Return on Equity (ROE)	13.26%
Return on Assets (ROA)	7.65%
Return on Capital (ROIC)	9.28%
Revenue Per Employee	2.21M
Profits Per Employee	237,073
Employee Count	1,025
Asset Turnover	0.97
Inventory Turnover	4.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.65%
50-Day Moving Average	620.76
200-Day Moving Average	426.28
Relative Strength Index (RSI)	51.99
Average Volume (20 Days)	13,361

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jagsonpal Pharmaceuticals had revenue of INR 2.27 billion and earned 243.00 million in profits. Earnings per share was 9.04.

Revenue	2.27B
Gross Profit	1.40B
Operating Income	286.23M
Pretax Income	322.94M
Net Income	243.00M
EBITDA	316.94M
EBIT	286.23M
Earnings Per Share (EPS)	9.04

Full Income Statement

Balance Sheet

The company has 778.45 million in cash and 98.14 million in debt, giving a net cash position of 680.31 million.

Cash & Cash Equivalents	778.45M
Total Debt	98.14M
Net Cash	680.31M
Net Cash Per Share	n/a
Equity (Book Value)	1.97B
Book Value Per Share	74.42
Working Capital	917.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 575.11 million and capital expenditures -2.53 million, giving a free cash flow of 572.58 million.

Operating Cash Flow	575.11M
Capital Expenditures	-2.53M
Free Cash Flow	572.58M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.88%, with operating and profit margins of 12.62% and 10.71%.

Gross Margin	61.88%
Operating Margin	12.62%
Pretax Margin	14.24%
Profit Margin	10.71%
EBITDA Margin	13.97%
EBIT Margin	12.62%
FCF Margin	25.24%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.76%.

Dividend Per Share	5.00
Dividend Yield	0.76%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	54.44%
Buyback Yield	-2.38%
Shareholder Yield	-1.62%
Earnings Yield	1.38%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a